Quick Answer
LISATA THERAPEUTICS, INC. reported Total Revenue of $170.0 thousand for fiscal year 2025.
LISATA THERAPEUTICS, INC. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $170.0K | -83.0% |
| 2024 | $1.00M | — |
| 2023 | $0.00 | -100.0% |
| 2016 | $35.28M | +56.9% |
| 2015 | $22.49M | +25.4% |
| 2014 | $17.94M | +22.3% |
| 2013 | $14.67M | +2.4% |
| 2012 | $14.33M | +42.6% |
| 2011 | $10.05M | -85.6% |
| 2010 | $69.82M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.00 | — | -100.0% |
| June 30, 2025 | $70.0K | — | — |
| September 30, 2024 | $0.00 | — | — |
| June 30, 2024 | $0.00 | — | -100.0% |
| March 31, 2017 | $7.92M | +5.8% | -15.0% |
| September 30, 2016 | $9.32M | +58.2% | +12.3% |
| June 30, 2016 | $8.30M | +41.5% | +10.8% |
| March 31, 2016 | $7.49M | +136.1% | +27.2% |
- LISATA THERAPEUTICS, INC. showed a decrease of -83.0% in Total Revenue compared to the prior fiscal year.
- Over the 2010–2025 period, LISATA THERAPEUTICS, INC.’s total revenue has declined by 99.8% (from $69.82 million to $170.0 thousand).
- The most recent figure is from LISATA THERAPEUTICS, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: